CRP and schizophrenia: If our findings are replicated, and CRP becomes established as a predictor of negative symptom severity, future studies should aim to elucidate the underlying pathophysiological mechanisms of the association, as this could inform the development of novel treatments for negative symptoms of schizophrenia.